Secondary endpoints included freedom from locoregional recurrence, freedom from distant recurrence, OS, cumulative incidence of second primary cutaneous squamous cell carcinoma tumors and safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback